BlackRock Health Sciences Trust (NYSE:BME) Shares Sold by HighTower Advisors LLC

HighTower Advisors LLC lessened its position in shares of BlackRock Health Sciences Trust (NYSE:BME) by 6.1% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 30,279 shares of the company’s stock after selling 1,973 shares during the quarter. HighTower Advisors LLC’s holdings in BlackRock Health Sciences Trust were worth $1,267,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. International Assets Investment Management LLC acquired a new position in BlackRock Health Sciences Trust in the 3rd quarter valued at about $8,610,000. Raymond James Trust N.A. raised its stake in BlackRock Health Sciences Trust by 8.1% in the 2nd quarter. Raymond James Trust N.A. now owns 22,036 shares of the company’s stock valued at $900,000 after purchasing an additional 1,649 shares during the last quarter. Calamos Advisors LLC raised its stake in BlackRock Health Sciences Trust by 46.4% in the 2nd quarter. Calamos Advisors LLC now owns 7,884 shares of the company’s stock valued at $322,000 after purchasing an additional 2,500 shares during the last quarter. Cambridge Investment Research Advisors Inc. raised its stake in BlackRock Health Sciences Trust by 4.3% in the 2nd quarter. Cambridge Investment Research Advisors Inc. now owns 54,605 shares of the company’s stock valued at $2,231,000 after purchasing an additional 2,240 shares during the last quarter. Finally, Fountainhead AM LLC acquired a new position in BlackRock Health Sciences Trust in the 3rd quarter valued at about $204,000.

BlackRock Health Sciences Trust Price Performance

Shares of BME stock opened at $38.10 on Tuesday. The firm has a 50-day moving average price of $40.19 and a 200 day moving average price of $40.84. BlackRock Health Sciences Trust has a twelve month low of $38.00 and a twelve month high of $42.86.

BlackRock Health Sciences Trust Dividend Announcement

The firm also recently declared a monthly dividend, which will be paid on Monday, December 23rd. Shareholders of record on Monday, December 16th will be issued a $0.2621 dividend. This represents a $3.15 annualized dividend and a yield of 8.26%. The ex-dividend date is Monday, December 16th.

About BlackRock Health Sciences Trust

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.